Clopidogrel and 1-year freedom from amputation after endovascular lower extremity revascularization in the Medicare population.

Objective: To evaluate freedom from amputation in patients identified utilizing clopidogrel following their lower extremity endovascular revascularization (LER).

Methods: Patients, 65 years of age and older, undergoing LER were identified from Medicare Provider Analysis and Review and Carrier files utilizing International Classification of Diseases diagnosis and Current Procedural Terminology codes. Postprocedural use of clopidogrel was identified using the National Drug Code directory.

Screening laboratory and radiology panels for trauma patients have low utility and are not cost effective.

Background: Routine laboratory and radiology panels as part of the initial evaluation of the trauma patient are prevalent practices. This is a study of utility and cost effectiveness of this practice.

Methods: During a 3-month period, trauma panels were analyzed for cost and impact on patient care in our institution.